Stroke Prevention

Bradford B. Worrall

doi:10.1055/s-2006-933303

Seminars in Neurology, Table of Contents

Semin Neurol 2006; 26(1): 005-008
DOI: 10.1055/s-2006-933303

PREFACE

Stroke Prevention

Bradford B. Worrall¹ Guest Editor

¹Department of Neurology, University of Virginia, Charlottesville, Virginia

Abstract

Full Text

References

REFERENCES

1 Kissela B, Schneider A, Kleindorfer D et al.. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004; 35 426-431
2 Schneider A T, Kissela B, Woo D et al.. Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke. 2004; 35 1552-1556
3 White H, Boden-Albala B, Wang C et al.. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005; 111 1327-1331
4 NINDS .Proceedings of the NINDS Stroke Disparities Advisory Panel Meeting, November 7-8, 2002. Bethesda, Maryland; Available at: http://www.ninds.nih.gov/news_and_events/proceedings/2002_clinical_research_workshop.htm Accessed July 17, 2005
5 Mozaffarian D, Kumanyika S K, Lemaitre R N et al.. Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA. 2003; 289 1659-1666
6 Mozaffarian D, Longstreth Jr W T, Lemaitre R N et al.. Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. Arch Intern Med. 2005; 165 200-206
7 Cronin S, Furie K L, Kelly P J. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke. 2005; 36 1581-1587
8 Kelly P J, Kistler J P, Shih V E et al.. Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke. 2004; 35 12-15
9 Meschia J F, Brott T G, Brown Jr R D et al.. The Ischemic Stroke Genetics Study (ISGS) protocol. BMC Neurol. 2003; 3 4
10 Meschia J F, Brown Jr R D, Brott T G et al.. The Siblings with Ischemic Stroke Study (SWISS) protocol. BMC Med Genet. 2002; 3 1
11 Meschia J F, Brott T G, Brown Jr R D et al.. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol. 2005; 58 351-361
12 Wright V L, Olan W, Dick B et al.. Assessment of CE-MRA for the rapid detection of supra-aortic vascular disease. Neurology. 2005; 65 27-32
13 Nadareishvili Z G, Li H, Wright V et al.. Elevated pro-inflammatory CD4+CD28-lymphocytes and stroke recurrence and death. Neurology. 2004; 63 1446-1451
14 DeGraba T J. Immunogenetic susceptibility of atherosclerotic stroke: implications on current and future treatment of vascular inflammation. Stroke. 2004; 35(suppl 1) 2712-2719
15 Nadareishvili Z G, Koziol D E, Szekely B et al.. Increased CD8(+) T cells associated with Chlamydia pneumoniae in symptomatic carotid plaque. Stroke. 2001; 32 1966-1972
16 Worrall B B, Azhar S, Nyquist P A et al.. Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis. Stroke. 2003; 34 790-793
17 Elkind M S, Lin I F, Grayston J T et al.. Chlamydia pneumoniae and the risk of first ischemic stroke: the Northern Manhattan Stroke Study. Stroke. 2000; 31 1521-1525
18 Elkind M S, Sciacca R R, Boden-Albala B et al.. Leukocyte count is associated with reduced endothelial reactivity. Atherosclerosis. 2005; 181 329-338
19 Cole J W, Pinto A N, Hebel J R et al.. Acquired immunodeficiency syndrome and the risk of stroke. Stroke. 2004; 35 51-56
20 Boden-Albala B, Sacco R L. Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress. Curr Atheroscler Rep. 2000; 2 160-166
21 Lin H F, Boden-Albala B, Juo S H et al.. Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia. 2005; 48 2006-2012
22 Kissela B M, Khoury J, Kleindorfer D et al.. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care. 2005; 28 355-359
23 Brown D L, Chervin R D, Hickenbottom S L et al.. Screening for obstructive sleep apnea in stroke patients: a cost-effectiveness analysis. Stroke. 2005; 36 1291-1293
24 Bushnell C D. The Women's Health Initiative trial and stroke risk. Lancet Neurol. 2002; 1 277
25 Bushnell C D, Newby L K, Goldstein L B et al.. Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology. 2004; 62 968-970
26 Marler J R. Help wanted: the best and the brightest neurologists to advance neurological treatments. Neurology Today. 2005; 5 4
27 NINDS .NINDS Clinical Research Collaboration Workshop: Exploring the Options. February 9, 2005. Available at: http://www.ninds.nih.gov/news_and_events/proceedings/2002_clinical_research_workshop.htm Accessed July 17, 2005
28 Chen D T, Miller F G, Rosenstein D L. Enrolling decisionally impaired adults in clinical research. Med Care. 2002; 40(suppl 9) V20-V29
29 Chen D T, Worrall B B, Brown Jr R D et al.. The impact of privacy protections on recruitment in a multicenter stroke genetics study. Neurology. 2005; 64 721-724
30 Chen D T. Curricular approaches to research ethics training for psychiatric investigators. Psychopharmacology (Berl). 2003; 171 112-119
31 Chen D T, Miller F G, Rosenstein D L. Clinical research and the physician-patient relationship. Ann Intern Med. 2003; 138 669-672

Bradford B WorrallM.D. M.Sc.

Department of Neurology, University of Virginia, HSC 800394, Charlottesville, VA 22908-0001